30 completed, 9 recruiting, 7 unknown, 2 terminated. 27 Not applicable, 7 Phase 1, 7 Phase 2, 4 Phase 4, 3 Phase 3.
Follow Organization and Administration: new trials by email Literature Review of Organization and Administration trials Research Report on Organization and Administration
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Shoulder Exercise Training on Pain, Range of Motion, and Functional Limitations in Women Following Unilateral Mastectomy Interventions 1. Scapular and Shoulder Exercise Program (Intervention Group) Supervision and Duration • 3 sessions/week • 45-60 minutes per session • Total duration: 8 weeks (24 sessions) • Conducted - Women Following Unilateral Mastectomy | Not applicable | Not yet recruiting | South Valley University | 33 | 2026-04-01 | 2026-03-20 |
| Duration of Surfactant Administration and Impact on Stabilisation of Vital Parameters in Very Preterm Neonates: 1 Minutes Versus 5 Minutes Poractant alfa (Curosurf®) - 1-minute administration, Poractant alfa (Curosurf®) - 5-minute administration - Neonates and Preterm Infants, Infant Respiratory Distress Syndrome | Phase 4 | Recruiting | Medical University of Graz | 76 | 2026-02-20 | 2026-05-14 |
| Effect of Sublingual Formulation of Dexmedetomidine Hydrochloride (HCl) (BXCL501) - Outpatient Study Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg, Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 1 | Recruiting | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 10 | 2025-07-28 | 2026-09-21 |
| H. Pylori Eradication With Argon Plasma During Endoscopy HEAPE, Pre-HEAPE - Helicobacter Pylori Infection, Helicobacter Pylori | Not applicable | Recruiting | Christopher C. Thompson, MD, MSc | 20 | 2025-07-08 | 2026-03-02 |
| Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Diabetes Psychological capability education, Physical capability education, motivation management - Type 2 Diabetes Mellitus | Not applicable | Completed | Capital Medical University | 30 | 2025-06-01 | 2026-03-16 |
| Synchronous and Asynchronous Telerehabilitation for Women With Urinary Incontinence BSATP Group, FtFS Group, Control Group (CG) - Urinary Incontinence,Stress | Not applicable | Recruiting | University of Patras | 60 | 2025-02-15 | 2025-02-27 |
| Updating Preventive and Treatment Guidelines for Hypoglycemia in Individuals Living With Type 1 Diabetes Oral Carbohydrate (CHO) Administration for Hypoglycemia Prevention and Treatment - Type 1 Diabetes | Not applicable | Recruiting | Institut de Recherches Cliniques de Montreal | 32 | 2025-02-06 | 2025-02-25 |
| A Digital Exercise Intervention in Patients With Spondyloarthritis Exercise with supervision, Exercise without supervision - Spondyloarthritis, Exercise | Not applicable | Recruiting | Diakonhjemmet Hospital | 260 | 2024-07-01 | 2026-08-20 |
| Remotely Supervised Computerized Cognitive Stimulation to Reduce Post-chemotherapy Cognitive Difficulties in Patients Treated for Localized Breast Cancer Cognitive exercises with supervision, Cognitive exercises without supervision - Breast Cancer, Cognitive Dysfunction | Not applicable | Recruiting | Centre Francois Baclesse | 300 | 2024-02-09 | 2025-09-19 |
| Implementation of Out-of-HOspital Administration of the Long-Acting Cabotegravir+Rilpivirine Hospital long-acting Vocabria (cabotegravir) 600 mg and long-acting Rekambys (rilpivirine) 900 mg administration, Out of Hospital long-acting Vocabria (cabotegravir) 600 mg and long-acting Rekambys (rilpivirine) 900 mg administration - HIV-1 Infection | Phase 4 | Completed | Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia | 103 | 2023-09-26 | 2025-07-14 |
| Harlem Strong Mental Health Coalition MH task-sharing training, Supervision, Learning Collaborative - Stress-related Problem, Depression, Anxiety | Not applicable | Recruiting | City University of New York, School of Public Health | 700 | 2023-04-05 | 2026-05-20 |
| Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies ORAL IMPACT treatment, control - Urological Manifestations | Not applicable | Unknown | Centre Hospitalier Intercommunal Robert Ballanger | 214 | 2022-11-30 | 2024-07-15 |
| A Clinical Trial in Healthy Volunteers and Patients With Mild Asthma to Investigate a New Medicine (AZD4604) for the Treatment of Asthma AZD4604 for inhalation via DPI, Placebo for AZD4604 for inhalation via DPI, AZD4604 for IV administration - Asthma | Phase 1 | Completed | AstraZeneca | 110 | 2022-07-08 | 2023-03-20 |
| Comparison of Icg's Route of Administration During Laparoscopic Cholecystectomy Indocyanine Green (ICG) administration - Laparoscopic; Cholecystectomy, Cholelithiasis; Bile Duct | Not applicable | Unknown | Aristotle University Of Thessaloniki | 240 | 2022-01-03 | 2022-03-10 |
| Implementation Strategies for Task-Shifting Depression Care Depression Care in Vietnam Workshop Training on Multicomponent Collaborative Care for Depression, Supervision, Community-Engaged Learning Collaborative - Depression | Not applicable | Completed | City University of New York, School of Public Health | 1382 | 2021-12-01 | 2025-12-16 |
| Effect of Sublingual Formulation of Dexmedetomidine HCl (BXCL501) - Alcohol Interaction Study Placebo, Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 40µg, Dexmedetomidine (DEX) for sublingual (SL) administration (BXCL501) - 80µg - Alcohol Use Disorder (AUD), Post Traumatic Stress Disorder (PTSD) | Phase 1 | Completed | Pharmacotherapies for Alcohol and Substance Use Disorders Alliance | 10 | 2021-11-09 | 2023-10-26 |
| Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study) Experimental: GLP1-RA (exenatide) administration, Control: Placebo administration - Hypopituitarism, Central Diabetes Insipidus | Phase 4 | Completed | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 42 | 2021-09-13 | 2026-01-20 |
| OCS-05 in Patients With Optic Neuritis OCS-05 +SoC (corticosteroid) IV administration, Placebo + SoC (corticosteroid) IV administration - Optic Neuritis | Phase 2 | Completed | Oculis | 36 | 2021-02-10 | 2025-09-22 |
| Clinical Trial to Evaluate the Safety and Immunogenicity of the COVID-19 Vaccine Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - Low dose, Two COVID-19 vaccine candidate (TMV-083/V-591) administrations - High dose, One COVID-19 vaccine candidate (TMV-083/V-591) administration - High dose - COVID-19 | Phase 1 | Completed | Institut Pasteur | 90 | 2020-08-10 | 2022-02-18 |
| Ensuring Quality in Psychological Support Ensuring Quality in Psychological Support, Standard Training and Supervision - Psychological Distress, Depression | Not applicable | Completed | George Washington University | 896 | 2020-06-20 | 2022-09-28 |
Showing 20 of 49. Sign in to see all of them.
Mental Disorders (4) · Depression (3) · Alcohol Drinking (2) · Alcoholism (2) · Behavioral Symptoms (2) · Breast Neoplasms (2) · Malaria (2) · Motor Activity (2) · Obesity (2) · Psychomotor Agitation (2) · Stress Disorders, Post-Traumatic (2) · Acquired Immunodeficiency Syndrome (1) · Alzheimer Disease (1) · Anxiety Disorders (1) · Asthma (1)
City University of New York, School of Public Health (2) · Pharmacotherapies for Alcohol and Substance Use Disorders Alliance (2) · Aristotle University Of Thessaloniki (1) · AstraZeneca (1) · Biogen (1) · Brown University (1) · Capital Medical University (1) · Centers for Disease Control and Prevention (1) · Centre Francois Baclesse (1) · Centre Hospitalier Intercommunal Robert Ballanger (1) · Christopher C. Thompson, MD, MSc (1) · Diakonhjemmet Hospital (1) · Elizabeth Glaser Pediatric AIDS Foundation (1) · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia (1)
United States (14) · France (8) · Spain (4) · Canada (3) · China (3) · Germany (3) · Sweden (3) · United Kingdom (3) · Belgium (2) · Denmark (2) · Greece (2) · Jordan (2) · Norway (2) · Uganda (2) · Australia (1)
Ismene Petrakis, MD (2) · Alison Schafer, PhD (1) · Amabelia Rodrigues, PhD (1) · Andre Lacroix, Master (1) · Anna Aulinas, MD PhD (1) · Barry J Byrne, MD, PhD (1) · Christina Studts, PhD (1) · Christopher C Thompson, MD (1) · Dan Nemet, Prof. MD (1) · Dave Singh (1) · David Isenberg, Prof (1) · Dimitra-Tania Papanikolaou (1) · Dr Pablo Forte Soto (1) · Florian Weck, PhD (1)
PMID 16437757, PMID 18419494, PMID 19712484, PMID 19923206, PMID 21556200, PMID 22794786, PMID 23043671, PMID 23272097, PMID 23570273, PMID 24009246, PMID 24106864, PMID 24314119, PMID 25162920, PMID 26286137, PMID 26645282, PMID 29746373, PMID 29976161, PMID 31270103, PMID 33432157, PMID 33712076, PMID 34034786, PMID 35045362, PMID 36593729, PMID 36639328, PMID 36814100, PMID 36922413, PMID 36991169, PMID 37022569, PMID 37507720, PMID 37596391, PMID 37815037, PMID 39300414, PMID 40216420, PMID 40354084, PMID 41231878, PMID 41392547, PMID 41901596, PMID 41916634, PMID 42389197
2015 (2), 2014 (1), 2025 (1), P01HL059412 (1)